Ignis Therapeutics
PrivateLast Round
Series A
Nov 11, 2021
Total Funding Raised
$185M
Company Overview
Ignis Therapeutics is a biotechnology company that develops and commercializes innovative therapies for central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ignis Therapeutics Comparables
Compare Ignis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tenacia Biotechnology | 89% | |
| NeuroFront Therapeutics | 79% | |
| NeuroGen Pharma | 77% | |
Ignis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 11, 2021 |
Ignis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Investment | Series A |
| HBM Healthcare Investments | Series A |
| 6 Dimensions Capital | Series A |
| Mubadala Investment Company | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2021
$185M round led by 6 Dimensions Capital.
Ignis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ignis Therapeutics's valuation, stock price, and market status.